KRYS compared with ARWR: revenue, margins and what each company keeps, and the suppliers and customers both name

KRYSKrystal Biotech, Inc.

Mkt capRevenueRevenue

ARWRArrowhead Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

KRYSKrystal Biotech, Inc.

ARWRArrowhead Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 500dMethod ›

Moved together

KRYSwithARWR

×0.51co-movement · ARWR on KRYS · 500d

r 0.32scale to r 0.75

Shared co-movers3with KRYSwith ARWR

DNLIDenali Therapeutics Inc.r 0.40r 0.49

SYRESpyre Therapeutics, Inc.r 0.39r 0.40

BEAMBeam Therapeutics Inc.r 0.39r 0.45

KRYS, solidARWR, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

KRYSKrystal Biotech, Inc.

295.30▼−11.13%· post 295.27

Mkt cap$8.8BRevenue$127MQ3 FY26Revenue$389MFY25

ARWRArrowhead Pharmaceuticals, Inc.

60.68▲+1.31%· post 59.68

ClosedNov 2 '26

Mkt cap$8.5BRevenue$75MQ3 FY26Revenue$829MFY25

Compare

ClosedNov 2 '26

KRYSKrystal Biotech, Inc.

ARWRArrowhead Pharmaceuticals, Inc.

295.30▼−11.13%post 295.27

Price

60.68▲+1.31%post 59.68

$8.8B

Mkt cap

$8.5B

Q3 FY26$127M

Revenue

$75MQ3 FY26

FY25$389M

Revenue

$829MFY25

KRYS295.30▼−11.13%vsARWR60.68▲+1.31%ClosedNov 2 '26